Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of chitosan nano material and preparation method thereof for lung cancer treatment

A technology of chitosan nano and chitosan, which is applied in the field of biomedicine, can solve problems such as poor water solubility, and achieve the effect of overcoming drug resistance

Inactive Publication Date: 2021-01-29
FUZHOU UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

), but its water solubility is poor

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of chitosan nano material and preparation method thereof for lung cancer treatment
  • A kind of chitosan nano material and preparation method thereof for lung cancer treatment
  • A kind of chitosan nano material and preparation method thereof for lung cancer treatment

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] 20 mg of N-4-azido-phthalimido-chitosan CS-N 3 (purchased from Shanghai Boao Biotechnology Co., Ltd., chitosan with a molecular weight of 60 KDa and a deacetylation degree of 90% as raw materials) was added to 2 mL of dimethyl sulfoxide, stirred until it was completely dissolved, and then placed in a flask 4 mg Er, 16 mg Q-amine and 4 mg of Cy7 were added to The above system was placed in a nitrogen atmosphere, and 200 μL of an aqueous solution of copper sulfate pentahydrate (20 mg / mL) and 200 μL of an aqueous solution of sodium vitamin C (15 mg / mL) were sequentially added dropwise to the flask with a 1 mL syringe. Wrap the flask with foil and stir at room temperature for three days. The reaction solution was taken out and put into a dialysis bag (8000-14000 Da) for dialysis for three days. The dialysate was taken out and freeze-dried to obtain CE7Q. Infrared spectrum analysis of CE7Q, such as figure 1 Shown, Cs-N 3 at 2100 cm -1 There is a strong absorption peak ...

Embodiment 2

[0039] 21 mg of N-4-azido-phthalimido-chitosan CS-N 3 (purchased from Shanghai Boao Biotechnology Co., Ltd., chitosan with a molecular weight of 60 KDa and a deacetylation degree of 90% as raw materials) was added to 2 mL of dimethyl sulfoxide, stirred until it was completely dissolved, and then placed in a flask Added 3 mg Er, 27 mg Q-amine and 3 mg of Cy7. The above system was placed in a nitrogen atmosphere, and 200 μL of an aqueous solution of copper sulfate pentahydrate (20 mg / mL) and 200 μL of an aqueous solution of sodium vitamin C (15 mg / mL) were added dropwise to the flask with a 1 mL syringe. Wrap the flask with foil and stir at room temperature for three days. The reaction solution was taken out and put into a dialysis bag (8000-14000 Da) for dialysis for three days. The dialysate was taken out and freeze-dried to obtain CE7Q. The grafting rates of Er, Cy7 and Q-amine in CE7Q were calculated to be 10%, 10% and 80%, respectively.

Embodiment 3

[0041] 20 mg of N-4-azido-phthalimido-chitosan CS-N 3 (purchased from Shanghai Boao Biotechnology Co., Ltd., chitosan with a molecular weight of 60 KDa and a deacetylation degree of 90% as raw materials) was added to 2 mL of dimethyl sulfoxide, stirred until it was completely dissolved, and then placed in a flask 7 mg Er, 6 mg Q-amine and 10 mg of Cy7 were added to The above system was placed in a nitrogen atmosphere, and 200 μL of an aqueous solution of copper sulfate pentahydrate (20 mg / mL) and 200 μL of an aqueous solution of sodium vitamin C (15 mg / mL) were sequentially added dropwise to the flask with a 1 mL syringe. Wrap the flask with foil and stir at room temperature for three days. The reaction solution was taken out and put into a dialysis bag (8000-14000 Da) for dialysis for three days. The dialysate was taken out and freeze-dried to obtain CE7Q. The grafting rates of Er, Cy7 and Q-amine in CE7Q were calculated to be 40%, 40% and 20%, respectively.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
degree of graftingaaaaaaaaaa
degree of graftingaaaaaaaaaa
degree of graftingaaaaaaaaaa
Login to View More

Abstract

The invention discloses a chitosan nano material (erlotinib-quaternary ammonium salt-heptamethine dye-chitosan, CE7Q) for lung cancer treatment and a preparation method thereof. The nano material is a CE7Q nano material formed by modifying the molecular targeting drug erlotinib, quaternary ammonium salt and heptamethine dye on the surface of chitosan. The CE7Q nanomaterial has both molecular targeting and good photothermal conversion efficiency, realizes the combination of photothermal therapy and molecular targeted therapy, and improves the sensitivity of lung cancer drug-resistant cells to erlotinib.

Description

technical field [0001] The invention belongs to the field of biomedicine, and in particular relates to a chitosan nano material used for treating lung cancer and a preparation method thereof. Background technique [0002] Non-small cell lung cancer (NSCLC) is one of the most common malignant tumors in my country, and its treatment has made some progress in the past few decades, but the survival data of advanced patients are still disappointing. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), as a targeted drug that effectively inhibits tumor cell growth, have brought about major changes in the treatment of NSCLC. In a short period of time, EGFR-TKIs became the first-line treatment for advanced NSCLC patients with EGFR mutations (Nan X, Xie C, Yu X, et al. EGFR TKI as first-line treatment for patients with advanced EGFR mutation-positive non- small-cell lung cancer. [J]. Oncotarget, 2017, 8(43):75712-75726.). Erlotinib (Er), as a representative drug...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K49/00A61K47/69A61K47/61A61K47/54A61K41/00A61K31/517A61P35/00
CPCA61K31/517A61K41/0052A61K49/0032A61K47/545A61K47/61A61K47/6939A61P35/00A61K2300/00
Inventor 高瑜李子颖朱立胜叶金祥陈海军
Owner FUZHOU UNIV